Genetics of COPD

Chest

Volumn 125, Issue 5, 2004, Pages 1929-1940

  Molfino, Néstor A ^a  

^a OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

Candidate gene; Chronic bronchitis; Emphysema; Genome; Linkage; Positional cloning; Pulmonary

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE;

CAUSE OF DEATH; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; EMPHYSEMA; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; MORTALITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 2442628171     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.5.1929     Document Type: Article

References (65)

1. National Institutes of Health, National Heart, Lung, and Blood Institute. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Workshop, 2003. Available at: http:// www.goldcopd.com. Accessed April 12, 2004
2. O'Donnell DE, Aaron S, Boerbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2003. Can Respir J 2003; 10(suppl): 11A-33A
3. Burge PS, Calverley PMA, Jones PW, et al. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax 2003; 58:654-658
4. Calverley PMA, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58:659-664
5. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 2003; 54:113-129
6. Rahman I. Oridative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 2003; 36:95-109
7. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003; 21:892-905
8. Rogers DF. The airway goblet cell. Int J Biochem Cell Biol 2003; 35:1-6
9. Maestrelli P, Saetta M, Mapp CE, et al. Remodeling in response to infection and injury: airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:876-580
10. Cosio MG, Hale KA, Niewoehner DE. Morphologic and morphometric effects of prolonged cigarette smoking on the small airways. Am Rev Respir Dis 1980; 122:265-271
11. Clarke SW. Rationale of airway clearance. Eur Respir J 1989; 7:599s-603s
12. Riise GC, Larsson S, Andersson BA. Bacterial adhesion to oropharyngeal and bronchial epithelial cells in smokers with chronic bronchitis and in healthy nonsmokers. Eur Respir J 1994; 7:1759-1764
13. Nadel JA. Role of neutroplul elastase in hypersecretion during COPD exacerbations, and proposed therapies. Chest 2000; 117:386S-389S
14. Rahman I, van Schadewijk AAM, Crowther AJL, et al. 4-hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:490-495
15. Suga T, Kurabayashi M, Sando Y, et al. Disruption of the klotho gene causes pulmonary emphysema in mice: defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol 2000; 22:26-33
16. Tuder RM, Zhen L, Cho CY, et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003; 29:88-97
17. Drazen JM. Asthma and the human genome project: summary of the 45th Annual Thomas L. Petty Aspen Lung Conference. Chest 2003; 123(suppl):447S-449S
18. Howard TD, Meyers DA, Bleecker ER. Mapping susceptibility genes for allergic diseases. Chest 2003; 123(suppl): 363S-368S
19. Joost O, Wilk JB, Cupples A, et al. Genetic loci influencing lung function: a genome-wide scan in the Framingham study. Am J Respir Crit Care Med 2002; 165:795-799
20. Wilk JB, DeStefano AL, Arnett DK, et al. A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Respir Crit Care Med 2003; 167:1528-1533
21. Silverman EK, Palmer LJ, Mosley JD, et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002; 70:1229-1239
22. Falk GA, Briscoe WA. Alpha-1-antitrypsin deficiency in chronic obstructive pulmonary disease. Ann Intern Med 1970; 72:427-429
23. 1 in a community population. Chest 2003; 123:1435-1440
24. Dahl M, Tybjaerg-Hansen A, Lange P, et al. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002; 136:270-279
25. Tarjan E, Magyar P, Vaczi Z, et al. Longitudinal lung function study in heterozygous PiMZ phenotype subjects. Eur Respir J 1994; 7:2199-2204
26. Silverman E, Chapamn H, Drazen J, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998; 157:1770-1778
27. McCloskey SC, Patel BD, Hinchliffe SJ, et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001; 164:1419-1424
28. Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58:388-393
29. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121(suppl):121S-126S
30. Sandford AJ, Weir TD, Spinelli JJ, et al. Z and S mutations of the alpha 1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 1999; 20:287-291
31. Alvarez-Granda L, Cabero-Perez MJ, Bustamante-Riuz A, et al. PI SZ phenotype in chronic obstructive pulmonary disease. Thorax 1997; 52:659-661
32. Turino GM, Barker AF, Brandy ML, et al. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency: Alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1996; 154:1718-1725
33. Sandford AJ, Chagani T, Weir TD, et al. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 2001; 163:469-473
34. Joos L, He JQ, Shepherdson MB, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002; 11:569-576
35. Sakao S, Tatsuini K, Igari H, et al. Association of tumor necrosis factor {alpha} gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:420-422
36. van der Pouw Kraan TC, Kucukaycan M, Bakker AM, et al. Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun 2003; 3:436-439
37. He JQ, Ruan J, Connett JE, et al. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002; 166:323-328
38. Koyama H, Geddes DM. Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease. Thorax 1998; 53: S10-S14
39. Schellenberg D, Pare P, Weir T, et al. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998; 157:957-961
40. Khoury MJ, Beaty TH, Newill CA, et al. Genetic-environmental interactions in chronic airways obstruction. Int J Epidemiol 1986; 15:65-72
41. Poller W, Meisen C, Olek K. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Invest 1990; 20:1-7
42. Hirai H, Kubo H, Yamaya M, et al. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 2003; 102:1619-1621
43. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 2003; 28:555-562
44. Carnevali S, Petruzzelli S, Longoni B, et al. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2003; 284:L955-L963
45. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001; 17:946-953
46. Boschetto P, Miniati M, Miotto D, et al. Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J 2003; 21:450-454
47. Silverman EK, Mosley J, Rao DC, et al. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases. Hum Hered 2001; 52:223-232
48. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 1986; 89:370-373
49. Silverman EK, Province MA, Campbell EJ, et al. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits. Genet Epidemiol 1992; 9:317-331
50. Seersholm N, Kok-Jensen A. Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema? Respir Med 1998; 92:241-245
51. Poller W, Faber JP, Weidinger S, et al. A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 1993; 17:740-743
52. Ferrarotti I, Zorzetto M, Beccaria M, et al. Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur Respir J 2003; 21:444-449
53. Sakao S, Tatsumi K, Igari H, et al. Association of tumor necrosis factor-{alpha} gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest 2002; 122:416-420
54. Minematsu N, Nakamura H, Tateno H. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 2001; 289:116-119
55. Smith CAD, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350:630-633
56. Yamada N, Yamaya M, Okinaga S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000; 66:187-195
57. Hirano K, Sakamoto T, Uchida Y, et al. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2001; 18:748-752
58. Silverman EK, Mosley JD, Palmer LJ, et al. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum Mol Genet 2002; 11:623-632
59. Gasparini P, Savoia A, Luisetti M, et al. The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 1990; 2:297-299
60. Tzetis M, Efthymiadou A, Strofalis S, et al. CFTR gene mutations-including three novel nucleotide substitutions-and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 2001; 108:216-221
61. Palmer LJ, Celedon JC, Chapman HA, et al. Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet 2003; 12:1199-1210
62. D'amato M, Vitiani L, Petrelli G, et al. Association of persistent bronchial hyperresponsiveness with beta 2-Adrenoceptor (ADRB2) haplotypes: a population study. Am J Respir Crit Care Med 1998; 158:1968-1973
63. Taylor DR, Drazen JM, Herbison GP, et al. Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphism. Thorax 2000; 55:762-767
64. Joos L, Weir TD, Connett JE, et al. Polymorphisms in the {beta}2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax 2003; 58:703-707
65. Ho LI, Harn HJ, Chen CJ, et al. Polymorphisms of the {beta}2-adrenoceptor in COPD in Chinese subjects. Chest 2001; 120:1493-1499